![]() Study Objectives: Verify and characterize abnormally expressed vitreous proteins in adults with full thickness macular holes (MH) versus vitreous from a floaterectomy control group.ĭescription: Randomized Trial Comparing Immediate versus Deferred Surgery for Symptomatic Epiretinal Membranes Despite improved glycemic control for many patients, Diabetic Retinopathy progresses in a large majority of patientsĭescription: Vitreous Proteomics in Eyes with a Macular Hole Study Objectives: To assess the ability of oral Fenofibrate to prevent progression of Diabetic Retinopathy in an at risk population (mild to moderately-severe NPDR). Pathology: Non-Proliferative Diabetic Retinopathy (NPDR)ĭescription: A Randomized Clinical Trial Evaluating Fenofibrate for Prevention of Diabetic Retinopathy Worsening Study Objectives: To determine the efficacy of intravitreal 2.0 mg OPT-302 when administered in combination with intravitreal 2.0 mg aflibercept, in participants with neovascular AMD Pathology: Neovascular Age-Related Macular Degeneration (nAMD)ĭescription: A Phase 3, multicentre, double-masked, randomized study to evaluate the efficacy and safety of intravitreal OPT-302 in combination with aflibercept, between changes in retina function with the severity of diabetic retinopathy. ![]() Study Objectives: The primary objective is to evaluate the safety and tolerability of single and multiple intravitreal injection(s) of OLX10212 in patients with neovascular AMD. Pathology: Wet Age-Related Macular Degeneration (AMD)ĭescription: A Phase 1, Multicenter, Open-Label, Single- and Multi-Dose, Dose-Escalating Clinical Study to Evaluate the Safety and Tolerability of OLX10212 Administered by Intravitreal Injection in Patients With Neovascular Age-Related Macular Degeneration Study Objectives: To evaluate the efficacy of QA102 oral capsules on the development/progression of geographic atrophy and/or development of CNV in patients with intermediate to small lesion advanced dry AMD. We are also actively involved in retinal research and clinical trials.Pathology: High Risk Intermediate Age-Related Macular Degeneration (AMD) or Small Lesion Geographic Atrophy (GA)ĭescription: A Phase 2, Double-Masked, Randomized, Placebo-Controlled, Dose-Response Study Assessing the Safety and Efficacy of AQ102 in Subjects with dry AMD Our on-call physician and triage staff are available 24/7 after hours, on weekends, and on holidays for emergencies. Treatments include vitrectomy, scleral buckle, and intravitreal injections (Avastin, Eylea, Lucentis, Vabysmo, etc.). ![]() Our retinal specialists and surgeons treat multiple vitreoretinal conditions, including age-related macular degeneration (AMD), diabetic retinopathy, retinal tears and detachments, macular holes and puckers, flashes and floaters, pediatric retinal conditions, and more. We have eight retina centers throughout South Carolina in Beaufort, Ladson, Lake City, Mount Pleasant, Orangeburg, and Walterboro, as well as two in Charleston (West Ashley and The Cigar Factory).Īll of our retina centers feature state-of-the-art diagnostic and testing techniques, like fluorescein angiography and optical computed tomography (OCT).
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |